{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:50:14Z","timestamp":1791366614646,"version":"4.3.1"},"reference-count":31,"publisher":"Georg Thieme Verlag KG","issue":"07","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug-resistant epilepsy (DRE) affects 30% of patients with epilepsy. Although multiple risk factors (RFs) are recognized, there are few studies that explore the differences in clinical presentation, etiology and RFs considering the sex, especially in Latin America.<\/jats:p>\n                  <jats:p>To analyze sex differences in clinical features, outcomes and RFs for DRE in patients enrolled in 2 hospitals of Buenos Aires between 2020 and 2022.<\/jats:p>\n                  <jats:p>Multicenter retrospective cohort study. Clinical variables, epilepsy characteristics, and complementary studies of patients over 18 years with epilepsy were collected. Descriptive analyses, bivariate comparisons (Chi-squared, t-test\/Mann-Whitney U test) and logistic regressions were applied to adjust for confounding factors.<\/jats:p>\n                  <jats:p>A total of 122 patients were included, of whom 44 had DRE. The prevalence of DRE was slightly higher in men than in women (39.6 vs. 33.3%). Male sex showed 4 RFs for DRE: personal history (odds ratio [OR]: 7.82; 95%CI: 1.54\u201339.51), magnetic resonance imaging (MRI) with abnormal findings (OR: 4.40; 95%CI: 1.26\u201315.41), symptomatic etiology (OR: 4.77; 95%CI: 1.44\u201315.77), and time of evolution (OR: 1.05; 95%CI: 1.00\u20131.06). In women, time of evolution was the only RF for DRE (OR: 1.04; 95%CI: 1.00\u20131.08).<\/jats:p>\n                  <jats:p>There are sex differences in clinical, etiological, and imaging features of DRE. It is important to incorporate a sex perspective into the initial assessment, as this could contribute to the early identification of patients with higher risk of DRE. Particularly in men with clinical factors associated with higher risk, it would be advisable to implement earlier and more intensive follow-up strategies.<\/jats:p>","DOI":"10.1055\/s-0046-1827051","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:16:11Z","timestamp":1786662971000},"page":"001-009","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for drug-resistant epilepsy according to sex: a cohort study conducted in a middle-income country"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6094-9937","authenticated-orcid":false,"given":"Ignacio","family":"Lagger","sequence":"additional","affiliation":[{"name":"Pontificia Universidad Cat\u00f3lica Argentina, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, Instituto de Investigaciones Biom\u00e9dicas, Buenos Aires, Argentina."},{"name":"Hospital General de Agudos Dr. Teodoro \u00c1lvarez, Departamento de Neurolog\u00eda, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3076-6168","authenticated-orcid":false,"given":"Sol","family":"Pacha","sequence":"additional","affiliation":[{"name":"Hospital Brit\u00e1nico de Buenos Aires, Departamento de Neurolog\u00eda, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-7541","authenticated-orcid":false,"given":"Eliana","family":"Garino","sequence":"additional","affiliation":[{"name":"Hospital General de Agudos Dr. Teodoro \u00c1lvarez, Departamento de Neurolog\u00eda, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-975X","authenticated-orcid":false,"given":"Oscar","family":"Martinez","sequence":"additional","affiliation":[{"name":"Hospital Brit\u00e1nico de Buenos Aires, Departamento de Neurolog\u00eda, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0457-3940","authenticated-orcid":false,"given":"Eduardo","family":"Knorre","sequence":"additional","affiliation":[{"name":"Hospital General de Agudos Dr. Teodoro \u00c1lvarez, Departamento de Neurolog\u00eda, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2772-8184","authenticated-orcid":false,"given":"Glenda","family":"Ernst","sequence":"additional","affiliation":[{"name":"Hospital Brit\u00e1nico de Buenos Aires, Comit\u00e9 Cient\u00edfico, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref1","volume-title":"Global comparative assessments in the health sector: disease burden, expenditures and intervention packages","author":"C JL Murray","year":"1994"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1046\/j.1528-1157.2002.t01-1-26901.x","article-title":"Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures","volume":"43","author":"I AW Kotsopoulos","year":"2002","journal-title":"Epilepsia"},{"issue":"01","key":"ref3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"P N Banerjee","year":"2009","journal-title":"Epilepsy Res"},{"issue":"06","key":"ref4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/epi.12633","article-title":"A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy","volume":"55","author":"J F T\u00e9llez-Zenteno","year":"2014","journal-title":"Epilepsia"},{"issue":"06","key":"ref5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"P Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"02","key":"ref6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.016","article-title":"Neuroendocrine aspects of catamenial epilepsy","volume":"63","author":"D S Reddy","year":"2013","journal-title":"Horm Behav"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nbd.2014.06.010","article-title":"Neurosteroids and their role in sex-specific epilepsies","volume":"72","author":"D S Reddy","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"03","key":"ref8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1124\/jpet.110.169854","article-title":"The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors","volume":"334","author":"D S Reddy","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","article-title":"Gender differences in pharmacological response","volume":"83","author":"G D Anderson","year":"2008","journal-title":"Int Rev Neurobiol"},{"issue":"06","key":"ref10","doi-asserted-by":"publisher","first-page":"e00541","DOI":"10.1002\/prp2.541","article-title":"Individualized medicine: Sex, hormones, genetics, and adverse drug reactions","volume":"7","author":"A M Moyer","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"03","key":"ref11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"O P Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"109801","DOI":"10.1016\/j.yebeh.2024.109801","article-title":"Quality of life in people with epilepsy: Associations with resilience, internalized stigma, and clinical factors in a low-income population","volume":"155","author":"F P Du Rausas","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"02","key":"ref13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14581\/jer.18013","article-title":"Quality of Life and Its Determinants in Adult Drug Refractory Epilepsy Patients Who Were Not Candidates for Epilepsy Surgery: A Correlational Study","volume":"8","author":"I Puri","year":"2018","journal-title":"J Epilepsy Res"},{"issue":"04","key":"ref14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"I E Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0140-6736(23)02807-6","article-title":"WHO's adoption of SAGER guidelines and GATHER: setting standards for better science with sex and gender in mind","volume":"403","author":"S Heidari","year":"2024","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.expneurol.2014.04.009","article-title":"Sex differences in human epilepsy","volume":"259","author":"I Savic","year":"2014","journal-title":"Exp Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"100140","DOI":"10.1016\/j.lana.2021.100140","article-title":"Burden of epilepsy in Latin America and The Caribbean: a trend analysis of the Global Burden of Disease Study 1990 - 2019","volume":"8","author":"K Pacheco-Barrios","year":"2021","journal-title":"Lancet Reg Health Am"},{"issue":"12","key":"ref18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.medcli.2023.03.006","article-title":"Risk factors for drug-resistant epilepsy in adult patients","volume":"160","author":"I Lagger","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"107790","DOI":"10.1016\/j.neuropharm.2019.107790","article-title":"Pharmacoresistance \u2013 Epidemiology, Mechanisms, and Impact on Epilepsy Treatment","volume":"168","author":"M Janmohamed","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2147\/NDT.S256699","article-title":"Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies","volume":"17","author":"D Guery","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"03","key":"ref21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3906\/sag-2010-27","article-title":"Clinical predictors of drug-resistant epilepsy in children","volume":"51","author":"P Karao\u011flu","year":"2021","journal-title":"Turk J Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"105872","DOI":"10.1016\/j.nbd.2022.105872","article-title":"Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review","volume":"174","author":"Z Q Li","year":"2022","journal-title":"Neurobiol Dis"},{"issue":"10","key":"ref23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.seizure.2011.07.010","article-title":"Predictors of refractory epilepsy in north India: a case-control study","volume":"20","author":"M Tripathi","year":"2011","journal-title":"Seizure"},{"issue":"10","key":"ref24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/cns.13897","article-title":"Risk factors for Drug-resistant Epilepsy (DRE) and a nomogram model to predict DRE development in post-traumatic epilepsy patients","volume":"28","author":"T T Yu","year":"2022","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/epi.14596","article-title":"The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis","volume":"59","author":"L Kalilani","year":"2018","journal-title":"Epilepsia"},{"issue":"30","key":"ref26","doi-asserted-by":"publisher","first-page":"e16402","DOI":"10.1097\/MD.0000000000016402","article-title":"Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis","volume":"98","author":"X-P Wang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref27","doi-asserted-by":"publisher","first-page":"e0300930","DOI":"10.1371\/journal.pone.0300930","article-title":"A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME)","volume":"19","author":"C Fayad","year":"2024","journal-title":"PLoS One"},{"issue":"01","key":"ref28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41983-023-00647-1","article-title":"Clinical, radiological and electrophysiological predictors for drug-resistant epilepsy","volume":"59","author":"N T Abokrysha","year":"2023","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"06","key":"ref29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.13811","article-title":"Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors","volume":"26","author":"R Stevelink","year":"2019","journal-title":"Eur J Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"747958","DOI":"10.3389\/fneur.2021.747958","article-title":"Treatment Outcome and Risk Factors of Adult Newly Diagnosed Epilepsy: A Prospective Hospital-Based Study in Northeast China","volume":"12","author":"N Li","year":"2021","journal-title":"Front Neurol"},{"issue":"04","key":"ref31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/epi4.12632","article-title":"Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsy","volume":"7","author":"M S Cepeda","year":"2022","journal-title":"Epilepsia Open"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1827051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:57:00Z","timestamp":1791363420000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1827051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["s00461827051"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1827051","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}